Department of Pharmaceutics, Roland Institute of Pharmaceutical Sciences, Berhampur, 760 010, Biju Patnaik University of Technology, Rourkela, Odisha-769015, India.
Department of Pharmacy, School of Health Sciences, The Assam Kaziranga University, Koraikhowa, NH-37, Jorhat, 785006, Assam, India.
Curr Pharm Biotechnol. 2023;24(2):213-237. doi: 10.2174/1389201023666220329111920.
Platelet-inspired nanoparticles have ignited the possibility of new opportunities for producing similar biological particulates, such as structural cellular and vesicular components, as well as various viral forms, to improve biocompatible features that could improve the nature of biocompatible elements and enhance therapeutic efficacy. The simplicity and more effortless adaptability of such biomimetic techniques uplift the delivery of the carriers laden with cellular structures, which has created varied opportunities and scope of merits like; prolongation in circulation and alleviating immunogenicity improvement of the site-specific active targeting. Platelet-inspired nanoparticles or medicines are the most recent nanotechnology-based drug targeting systems used mainly to treat blood-related disorders, tumors, and cancer. The present review encompasses the current approach of platelet-inspired nanoparticles or medicines that have boosted the scientific community from versatile fields to advance biomedical sciences. Surprisingly, this knowledge has streamlined to development of newer diagnostic methods, imaging techniques, and novel nanocarriers, which might further help in the treatment protocol of the various diseased conditions. The review primarily focuses on the novel advancements and recent patents in nanoscience and nanomedicine that could be streamlined in the future for the management of progressive cancers and tumor targeting. Rigorous technological advancements like biomimetic stem cells, pH-sensitive drug delivery of nanoparticles, DNA origami devices, virosomes, nano cells like exosomes mimicking nanovesicles, DNA nanorobots, microbots, etc., can be implemented effectively for target-specific drug delivery.
血小板启发的纳米粒子为生产类似生物颗粒(如结构细胞和囊泡成分以及各种病毒形式)提供了新的机会,以改善生物相容性特征,从而提高生物相容元素的性质并增强治疗效果。这种仿生技术的简单性和更轻松的适应性提高了载有细胞结构的载体的递送,从而创造了各种机会和优点,如延长循环时间和减轻免疫原性,提高了特定部位的主动靶向性。血小板启发的纳米粒子或药物是基于纳米技术的最新药物靶向系统,主要用于治疗与血液相关的疾病、肿瘤和癌症。本综述包括了血小板启发的纳米粒子或药物的当前方法,这些方法激发了科学界从各个领域推进生物医学科学。令人惊讶的是,这些知识已经简化为开发更新的诊断方法、成像技术和新型纳米载体,这可能有助于各种疾病的治疗方案。该综述主要侧重于纳米科学和纳米医学的新进展和最新专利,这些专利可能在未来用于管理进展性癌症和肿瘤靶向。严格的技术进步,如仿生干细胞、纳米粒子的 pH 敏感药物递送、DNA 折纸装置、类病毒体、模拟纳米囊泡的外泌体样纳米细胞、DNA 纳米机器人、微机器人等,可以有效地用于靶向特定药物的递送。